Loading organizations...
§ Private Profile · Hanover, NH, USA
Biotechnology company offering gene therapy for eye disorders.
Hubble Therapeutics has raised $7.3M across 1 funding round.
Hubble Therapeutics has raised $7.3M in total across 1 funding round.
Hubble Therapeutics has raised $7.3M in total across 1 funding round.
Hubble Therapeutics's investors include WARF Ventures.
Hubble Therapeutics has raised $7.3M across 1 funding round. Most recently, it raised $7.3M Series A in March 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 25, 2025 | $7.3M Series A | Warf Ventures | — | Announced |